Europe, Emerging Markets Strong
Coca-Cola earned $0.46 a share in the first quarter on revenue of $11.04 billion. Analysts had only expected $0.45 and $10.94 billion, respectively. Management cited strong demand in Europe and emerging markets. KO advances almost 4 percent before the bell on my tradeMONSTER platform.
FDA Request Sends Sarepta Lower
The Food and Drug Administration asked Sarepta Therapeutics for additional information on its eteplirsen drug for the treatment of Duchenne muscular dystrophy. The summaries requested are to come from the existing data and won't require new research, but SRPT is still down by almost 7 percent in early trading.
Weak Admissions, Outlook Hurt HCA
Hospital operator HCA Holding warned that first-quarter revenue was only $8.44 million, less than the $8.63 billion number expected by analysts. Management cited weak admissions and outpatient levels. HCA drops 3 percent.
More From optionMONSTER
- Chicago Bridge pullback draws buyers
- Calls look for rebound in Exxon Mobil
- Trader sees SolarWinds losing power
- Health Care Industry
- Investment & Company Information
- Sarepta Therapeutics
- Food and Drug Administration